Chronic or unspecified gastric ulcer with hemorrhage
Methodology & AI Transparency ⓘ
Chronic or unspecified gastric ulcer with hemorrhage Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: For patients presenting with Chronic or unspecified gastric ulcer with hemorrhage (ICD-10-CM K25.4), Acid Reflux, GERD & Upper GI Health protocols prioritize ambulatory pH-impedance monitoring in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: when refractory) paired with baseline and interval Serum Vitamin B12 in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: & Magnesium (chronic) assessment.
- 2 Real-world patient consensus: Federal ICD-10-CM code K25.4 categorizes Chronic or unspecified gastric ulcer with hemorrhage under Acid Reflux, GERD & Upper GI Health.
- 3 Typical cash cost range: Clinicians assessing Chronic or unspecified gastric ulcer with hemorrhage focus on gastric acid/pepsin mucosal in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: backwash) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Chronic or unspecified gastric ulcer with hemorrhage: Serum Vitamin B12 in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: & Magnesium (chronic) (B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K25.4)) and H. pylori Stool in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: Antigen or Urea).
Ask our AI Specialists anything about Chronic or unspecified gastric ulcer with hemorrhage
What Is Chronic or unspecified gastric ulcer with hemorrhage?
For patients presenting with Chronic or unspecified gastric ulcer with hemorrhage (ICD-10-CM K25.4), Acid Reflux, GERD & Upper GI Health protocols prioritize ambulatory pH-impedance monitoring in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: when refractory) paired with baseline and interval Serum Vitamin B12 in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: & Magnesium (chronic) assessment.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Chronic or unspecified gastric ulcer with hemorrhage (ICD-10 K25.4) is driven by gastric acid/pepsin mucosal in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: backwash); specialists in Acid Reflux, GERD & Upper GI Health monitor H. pylori Stool in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: Antigen or Urea) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Chronic or unspecified gastric ulcer with hemorrhage (K25.4): post-meal retrosternal heartburn in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: or sour acid)
- • Secondary Chronic or unspecified gastric ulcer with hemorrhage clinical sign: epigastric burning, early in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: satiety, or upper-abdominal)
- • Symptom flares in Chronic or unspecified gastric ulcer with hemorrhage correlating with Serum Vitamin B12 in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: & Magnesium (chronic) deviation outside B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K25.4)
- • Functional gerd & stomach impact requiring ambulatory pH-impedance monitoring in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: when refractory) evaluation (K25.4)
Chronic or unspecified gastric ulcer with hemorrhage Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K25.4 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Acid Reflux, GERD & Upper GI Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: & Magnesium (chronic) | B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K25.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: H. pylori Stool in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: Antigen or Urea) | Negative (K25.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Hemoglobin & Serum in Chronic or unspecified gastric ulcer with hemorrhage (K25.4: Ferritin) | Ferritin > 50 ng/mL (no occult loss) (K25.4) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Chronic or unspecified gastric ulcer with hemorrhage
Treatment selection for Chronic or unspecified gastric ulcer with hemorrhage depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Chronic or unspecified gastric ulcer with hemorrhage)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Safety and real-world benefits of Semaglutide in Patients With Chronic Kidney: What a 12,785-Participant Study Found Semaglutide demonstrates a favourable safety profile and significant cardiorenal benefits in CKD patients, with or without T2DM. Endocrinology, diabetes & metabolism • 2025-11-15 • Meta-Analysis | N = 12,785 | 99/100 | PMID 41276951 ↗ |
| New Insights on Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart: What a 3,668-Participant Study Found Compared with placebo, a mean atrasentan exposure translated in a hazard ratio of 0.76 (95% confidence interval (CI): 0.28-0.85) for kidney events and 1.13 (95% CI: 1.03-2.20) for heart failure events. Clinical pharmacology and therapeutics • 2021-06-15 • Phase III Randomized Trial | N = 3,668 | 96/100 | PMID 33338269 ↗ |
| New Insights on Reductions in acute medication use and healthcare resource utilization in: What a 1,113-Participant Study Found Treatment with galcanezumab resulted in significant reductions in headache medication overuse and migraine headache days requiring acute medication use, with notable reductions in migraine-specific HCRU. Journal of medical economics • 2022-01-15 • Phase III Randomized Trial | N = 1,113 | 96/100 | PMID 35971655 ↗ |
| New Insights on Empagliflozin Reduces Risk of Hospitalization in Patients With Chronic Kidney: What a 6,609-Participant Study Found 1995 participants (1035 placebo, 960 empagliflozin) had ≥1 ACH (1895 ACH in placebo and 1611 in the empagliflozin 10-mg groups). Clinical therapeutics • 2025-12-15 • Phase III Randomized Trial | N = 6,609 | 96/100 | PMID 41047325 ↗ |
| New Insights on Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development,: What a 5,000-Participant Study Found Benefits also include improvements in quality of life, fewer psychiatric comorbidities, and reduced healthcare resource utilization. Medicine • 2023-07-01 • Phase III Randomized Trial | N = 5,000 | 96/100 | PMID 37499085 ↗ |
Chronic or unspecified gastric ulcer with hemorrhage Patient Community & “People Like Me” Threads
Filter Chronic or unspecified gastric ulcer with hemorrhage community threads and patient logs by age, biological sex, dosage, and treatment duration.